Free discreet shipping on every order · Licensed 503A pharmacy
Bimatoprost RxGet started

Bimatoprost / working resource

Observation and follow-up journal

Record what changed, when it changed and what else could explain it.

Start with the product-specific question

What the label says it is for

Bimatoprost for short or sparse eyelashes, with the evidence and its limits in plain view. What should I know about what the label says bimatoprost is for?

In a 2012 randomized trial, subjects were randomized over 5 months to once-daily bimatoprost 0.03% (n = 137) or vehicle (n = 141). A higher percentage of subjects treated with bimatoprost 0.03% (78.1%) than vehicle (18.4%) demonstrated at least a 1-grade increase in global eyelash assessment score at week 16 (P < .0001). The abstract lists the short-term duration of the trial and that black subjects were not enrolled secondary to technical requirements of digital image analysis as limitations.

Read the original record ↗
Open the Bimatoprost library ↗

Describe an observation without assuming a cause.

When researching Bimatoprost, stories about improvement can leave out other changes, time trends and ordinary variation. A clear record preserves those details. Use any monitoring plan agreed with your clinician; this blank journal does not supply one.

Entry 1

Entry 2

Entry 3

Entry 4

Review the record with context.

A personal timeline cannot establish that a product caused a benefit or harm. Seek appropriate care for concerning symptoms rather than waiting to complete a journal.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗